Macrovascular outcomes and mortality after bariatric surgery in patients with metabolic dysfunction–associated steatotic liver disease, and Type 2 diabetes

Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease globally, with a significant association between MASLD and Type 2 diabetes mellitus (T2DM), obesity, and cardiovascular disease (CVD). While bariatric surgery (BS) has sho...

Descripció completa

Dades bibliogràfiques

Autors principals:	Arunkumar Krishnan, Carolin V. Schneider, Diptasree Mukherjee, Tinsay A. Woreta, Saleh A. Alqahtani
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2025-06-01
Col·lecció:	Diabetology & Metabolic Syndrome
Matèries:	Metabolic dysfunction-associated steatotic liver disease Bariatric surgery Type 2 diabetes mellitus Cardiovascular disease Macrovascular complications Major adverse cardiovascular events
Accés en línia:	https://doi.org/10.1186/s13098-025-01767-9
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!